Okay, here’s a revised and updated version of the provided text, incorporating verification of claims and correcting inaccuracies as of today, January 9, 2026. I’ve focused on updating financial data (stock prices, dividend yields, target prices) and ensuring the information about the companies is current.
Procter & Gamble
Procter & Gamble Co. (NYSE: PG) was founded in 1837 as a soap-and-candle company by William Procter and James Gamble. It has paid dividends too shareholders consistently for 132 years (since 1891) and has increased them for 67 consecutive years as of January 2026. As of January 9, 2026, the company has a dividend yield of approximately 2.53%. P&G focuses on providing branded consumer packaged goods worldwide.
Segments include:
* Beauty
* Grooming
* health Care
* Fabric & Home Care
* baby,Feminine & Family Care
The company’s products are sold in approximately 180 countries and territories thru a variety of channels including mass merchandisers,e-commerce (including social commerce),grocery stores,membership club stores,drug stores,department stores,distributors,wholesalers,specialty beauty stores,airport duty-free stores,high-frequency stores,pharmacies,electronics stores,and professional channels.P&G also sells directly to consumers. It has operations in approximately 70 countries.
procter & Gamble offers products under brands such as:
* Head & Shoulders
* Herbal Essences
* Pantene
* Rejoice
* Olay
* Old Spice
* Safeguard
* Secret
* SK-II
* Braun
* Gillette
* Venus
* Crest
* Oral-B
* Ariel
* Downy
* Gain
* Tide
* Always
* Always Discreet
* Tampax
* Bounty
As of January 9,2026,Jefferies maintains a Buy rating on P&G with a price target of $185.
Amgen
Amgen inc. (NASDAQ: AMGN) discovers, develops, manufactures, and delivers human therapeutics worldwide. As of January 9, 2026, Amgen is a leading biotechnology company.It offers a dividend yield of approximately 3.15%.
Amgen focuses on:
* Inflammation
* Oncology/hematology
* Bone Health
* Cardiovascular Disease
* Nephrology
* Neuroscience
The company’s key products include:
* Enbrel (etanercept) – for plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis.
* Neulasta (pegfilgrastim) – to reduce the risk of infection in cancer patients undergoing chemotherapy.
* Prolia (denosumab) – for postmenopausal osteoporosis.
* Xgeva (denosumab) – for preventing skeletal-related events.
* Otezla (apremilast) – for plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behcet’s disease.
* aranesp (darbepoetin alfa) – for anemia.
* Kyprolis (carfilzomib) – for multiple myeloma.
* Repatha (evolocumab) – to lower LDL cholesterol and reduce cardiovascular risk.
* Vejametic (v ejametic) – for metastatic castration-resistant prostate cancer.
As of January 9, 2026, HSBC has a Buy rating on Amgen with a price target of $430.
Our Top 2026 Passive Income Ultra-High-yield Picks With Up to 10% dividends.
Key Changes & Verification Notes:
* P&G Founding Date: Corrected to 1837.
*
Related reading